The infection dynamics and pathology of a retrovirus may be altered by one or more additional viruses. To investigate this further, this study characterized proviral load, biodistribution and the immune response in Macaca fascicularis naturally infected with combinations of simian retrovirus type 2 (SRV-2) and simian T-cell lymphotropic virus type I (STLV-I). As the mesenteric lymph node (MLN) and the spleen have been implicated previously in response to retroviral infection, the morphology and immunopathology of these tissues were assessed. The data revealed a significant change in SRV-2 biodistribution in macaques infected with STLV-I. Pathological changes were greater in the MLN and spleen of STLV-I-infected and co-infected macaques compared with the other groups. Immune-cell populations in co-infected macaque spleens were increased and there was an atypical distribution of B-cells. These findings suggest that the infection dynamics of each virus in a co-infected individual may be affected to a different extent and that STLV-I appears to be responsible for enhancing the biodistribution and associated pathological changes in SRV-2 in macaques.
INTRODUCTION
The dynamics of a viral infection can be affected by coinfection with either homologous defective viral genomes or viruses of distinct classes (Schiffer et al., 2004) . In individuals infected by human immunodeficiency virus type 1 (HIV-1), the presence of human T-cell lymphotropic virus type 1 (HTLV-I) can result in an accelerated progression of HIV-1 infection to AIDS (Bartholomew et al., 1987; Brites et al., 2009; Gudo et al., 2009; Hattori et al., 1989; Lefrère et al., 1990; Page et al., 1990) . A comprehensive analysis of the pathological effect(s) of co-infection is difficult to study in humans due to the challenges in obtaining biopsy samples from multiple lymphoid tissues. Retroviral co-infections have been reported in non-human primates (NHPs). Thus, the study of NHPs infected with viruses related to human pathogens can aid our understanding of viral co-infection.
Both cynomolgus macaques (Macaca fascicularis) and rhesus macaques (Macaca mulatta) are natural hosts for simian retrovirus (SRV) and simian T-cell lymphotropic virus (STLV), and these infections are frequent both in the wild and in captivity (Falcone et al., 1999; Gardner et al., 1988; Henrickson et al., 1983; Marx et al., 1984; Mee et al., 2009; Richards et al., 1998) . In severe infections of macaques, SRV has been reported to cause morbidity, with a disease course indistinguishable from that of simian immunodeficiency virus (SIV), causing an immunosuppressive AIDS-like disease (SAIDS) (Grant et al., 1995; Lerche et al., 1987) . There is no known human homologue of SRV. STLV-I is associated with leukaemia and lymphoma and is the simian counterpart of HTLV-I (Tsujimoto et al., 1987; Voevodin et al., 1985) . The two viruses are highly similar, and the virological, immunological, molecular and pathological features are comparable (Moné et al., 1992; Traina-Dorge et al., 1992; Tsujimoto et al., 1987; Voevodin et al., 1985) .
Experimental dual infections with SIV in NHPs have provided useful insights into viral dynamics and host immunity. Dual infection with SIV is believed to potentiate STLV-I/HTLV-I-related disease but not exacerbate SIV burden or disease progression (Fultz et al., 1990 (Fultz et al., , 1999 Traina-Dorge et al., 2007) . In these co-infection studies, macaques were given a high-titre inoculum to maximize the chance of infection and accelerate progression to disease, which does not necessarily reflect the situation in naturally acquired infection in macaques or in humans. In natural infections, macaques and humans may be exposed multiple times to varying amounts of virus, and these infections may never lead to overt pathology. Many captive macaques are naturally infected with retroviruses and therefore provide an excellent opportunity to study the dynamics of retroviral co-infection, in particular to establish whether specific viruses impact on infection and the pathological potential of others in a host.
Previously, we characterized the infection dynamics and tissue pathology associated with naturally acquired SRV-2 infection (Mitchell et al., 2011) . Having defined the SRV-2 and STLV-I infection status of a group of captive-bred cynomolgus macaques (Mee et al., 2009) , this gave us the opportunity to study co-infection of these viruses, to consider whether viral burden and pathological changes coincided with the presence of an additional retrovirus. From the samples available from this study, we selected a subset of 16 macaques, the infection status of which was assessed by PCR. Macaques were grouped as: SRV/STLVnegative, SRV-2-infected, STLV-I-infected or STLV-I/SRV-2-infected. The proviral burden and distribution across a range of tissues including blood was measured. Lymphoid pathology was assessed in the mesenteric lymph node (MLN) and spleen, as we identified these previously as key immune sites in SRV infection (Mitchell et al., 2011) .
Our data indicated that the dynamics of STLV-I infection are minimally altered as a consequence of the presence of SRV-2. By contrast, an increase in SRV-2 proviral burden and a more marked immunopathological change in both the MLN and spleen were observed in co-infected macaques. This is the first report on the pre-disease effects of natural retrovirus co-infection of cynomologus macaques. Our data suggest that SRV-2 pathology is more susceptible to enhancement in the presence of STLV-I infection and thus co-infected macaques are more likely to succumb to SRV-2-associated disease.
RESULTS

Grouping of macaques
Macaques were grouped into infection categories according to their proviral DNA status from both PBMCs and tissues (Table 1) . For most animals there was concordance between detection of provirus in PBMCs and tissues; however, for macaques 768E, 963DBE, 088AD and 184E, provirus was undetectable in PBMCs but detectable in tissues ( Table 2 ). As this suggested that an accurate infection status could not be guaranteed if determined solely on information from the periphery, and given that the aim of our study was to determine whether immunopathological effects were associated with the presence of viral sequences in the tissues, macaque infection status was based on data from the tissues. Two animals (088AD and 176ABA) had detectable provirus but no detectable antibody response, perhaps indicative of a recent infection or the failure to generate a specific serological response. In addition, some macaques were seropositive for virus antigen, yet no detectable viral sequences were found in the PBMCs or tissues (017K, 768E, 604E and 542B). In these cases, it would appear that the animal had been exposed to the virus and the immune response may have been sufficient to maintain the levels of virus below the detection limit of the assays (,200 proviral DNA copies ml 21 for SRV and ,0.5 proviral DNA copies per reaction for STLV).
SRV-2 proviral burden is increased in the presence of STLV-I To determine the extent to which the proviral burden of SRV-2 and STLV-I is affected by the presence of the other retrovirus, the proviral loads for each virus were assessed in all tissues sampled (Table 2, Fig. 1 ). The total proviral load and the number of tissues with detectable STLV-I infection (biodistribution) were similar irrespective of whether the host was also infected with SRV-2 (Fig. 1a, b) . The mean proviral load for STLV-I was comparable between single and dual-infected macaques within individual tissue types, except for the spleen in which STLV-I was found at a higher level in co-infected macaques (Fig. 1c ). There was a statistically significant increase in the total number of tissues testing positive for SRV-2 in co-infected macaques ( Fig. 1a; P50.0372). Furthermore, the total SRV-2 proviral loads were higher in co-infected macaques compared with those infected with SRV-2 alone (Fig. 1b) . The mean number of SRV-2 proviral copies was higher in most of the co-infected macaque tissues apart from the tongue, where the highest mean copies were seen in SRV-2-infected macaques (Fig. 1d) . Furthermore, the highest total SRV-2 proviral loads were detected in two of the co-infected macaques (176ABA and 820A; Table 2 , Fig. 1b ).
Increasingly atypical MLN and spleen morphology is associated with co-infection
As the MLN and spleen have been identified as major sites of immunopathology in retrovirus-infected macaques (Mitchell et al., 2011) , haematoxylin and eosin (H&E) staining was performed on these tissues from all macaques to determine the effect of retroviral co-infection on tissue pathology. Overall, the tissue architecture of the MLN of macaques infected with SRV-2 was comparable to that seen in SRV/STLV-negative macaque tissue (Table 3 , Fig. 2a , macaque 958EH). Morphological differences were seen in the MLN from macaques infected with STLV-I and coinfected macaques, and are reported in Table 3 . In STLV-Iinfected macaques, the morphological differences ranged from enlarged follicles with a dispersed marginal and mantle zone (Fig. 2b) to an enlarged paracortex with very few follicles (Fig. 2c) . In SRV-2/STLV-I-infected macaques, follicular hyperplasia with either enlarged secondary follicles (Fig. 2d) or multiple small primary follicles was observed.
Histopathological abnormalities were observed in the spleens of all infection groups (Table 3 , Fig. 3 ) and in 
*Viraemia status in PBMCs at euthanasia. DTotal SRV-2/STLV-I proviral loads detected in the 11 tissues assessed. Detection limits: SRV-2 assay, 200 copies ml 21 ; STLV-I assay, 0.5 copies per reaction. 
15.3 +/2/+ 0.5 (4) 2 (0.5) 2 (2) 2 (10) 2 (7) 2 (1) 2 (2) 6 (2.5) 5.5 (2) 4 (5.5) 35 (2) 176ABA 13.9 +/+/+ 818 (1) 2 (2) 50 (7) ; STLV-I assay, 0.5 copies per reaction.
Effect of retroviral co-infection
one of the SRV/STLV-negative macaques ( Fig. 3b ; macaque 979B). In the red pulp, there was evidence of loss of cellular organization of the splenic cords and sinuses with giant cells present ( Fig. 3b ) and an increase in the number of trabeculae through the gland (Fig. 3c ). Changes were also observed in the white pulp regions including follicular secondary hyperplasia (Fig. 3d) , follicular primary hyperplasia ( Fig.  3e ) and irregular follicles with deposits in the germinal centre and follicular depletion (Fig. 3f) . The morphological abnormalities were present in all infection groups and these changes varied among individual macaques. Nevertheless, these abnormalities were more pronounced among the macaques infected with STLV-I and SRV-2/STLV-I compared with those infected with SRV-2 alone.
Immunopathological changes in the MLN and spleen of co-infected macaques
To determine whether populations of major immune cells were altered by retroviral co-infection, immunohistochemistry (IHC) was performed on MLN and spleen tissue. The immunostaining obtained was evaluated in terms of both the frequency of immunostained cells and the intensity of staining for T-cells, B-cells and macrophages, using a scoring system described previously (Mitchell et al., 2011) ( Table 4) .
Immunostaining of MLNs with anti-CD3 antibody for Tcells was higher in the SRV/STLV-I-negative macaques. By contrast, anti-CD3 immunostaining in SRV-2-and/or STLV-I-infected macaques was less intense, irrespective of the combination of viruses with which the macaques were infected. By contrast, the level of anti-CD20 staining for Bcells was highest in STLV-I-infected macaques, whilst broadly comparable frequencies of B-cell immunostaining were seen in the SRV/STLV-negative and SRV-2-and SRV-2/STLV-I-infected macaques. The levels of anti-CD68 staining for macrophages were lowest in the MLNs of SRV-2/STLV-I-infected macaques, both in the frequency of positive cells and the intensity of stained cells. Anti-CD68 immunostaining of the MLNs of all other macaques was broadly similar (Table 4 ).
In the spleen, elevated levels of T-cell, B-cell and macrophage immunostaining were detected for all macaques infected with SRV-2 and/or STLV-I compared with SRV-2/ STLV-I-negative macaques (Table 4 ). The highest levels of staining were observed in co-infected macaques. Representative sections from each infection group are presented in Fig. 4 . In addition to an increase in the frequency and intensity of immunostaining, changes were also observed in the position of staining for T-and B-cells. For a number of infected macaques, T-cells were no longer localized to the red pulp region but were also detected in the white pulp. This was evident in a number of macaques in all infection groups (Table 4 , Fig. 4c, d ). In addition, B-cells were no longer confined to the germinal centres and Effect of retroviral co-infection appeared to be redistributed into the marginal/mantle zone and the red pulp. This redistribution was observed in both STLV-I-and SRV-2/STLV-I-infected macaques but was more marked in the latter (Fig. 4g, h) . Furthermore, the morphology of cells immunostained for CD68 was altered. Enlarged cells were observed, suggesting the presence of socalled giant cells: this was evident in a number of macaques in all infection groups (Fig. 4l) .
DISCUSSION
In humans, the infection dynamics of a virus may be altered in the presence of a second infection. Information on the immunopathological effects of dual infections is limited, however. Whilst experimental studies in primates can provide useful insights into viral dynamics and host immunity, the data may not be truly representative of naturally acquired infection. We have reported previously on the immunopathological impact of naturally acquired SRV-2 infection in cynomolgus macaques (Mitchell et al., 2011) . Here, we investigated whether infection with more than one retrovirus altered the viral dynamics and immunopathology of each infection, as a model of what may occur in human retroviral co-infections.
From a previously identified cohort of macaques (Mee et al., 2009) , we selected individuals that had been shown to have SRV-2, STLV-I or dual SRV-2/STLV-I infection based on proviral detection in PBMCs. As we wished to understand the host response to viral sequences in the tissues, we further characterized the infection status of these animals in a range of tissues. Interestingly, we observed four macaques with undetectable provirus in their periphery but detectable virus in a number of their tissues (768E, 088AD, 963DBE and 184E). Hence, peripheral load does not necessarily reflect infection status. We thus characterized the infection status of the macaques by using data derived from analysis of their tissues. Additionally, four macaques were seropositive for viral antibodies in the absence of detectable provirus (017K, 768E, 604E and 542B). Whilst we recognize that an antibody response suggests that the animal has been exposed to antigen at some point, the status of the macaque's serological response was not used to establish infection status, as we were interested in characterizing host immunopathology in the presence of viral sequences. Thus, we classified the macaques according to their proviral status in the tissues.
All three STLV-I-infected macaques that were PCR negative (in both blood and tissue) but seropositive for SRV-2 were placed in the STLV-I infection group. The morphological and immunopathological changes in these macaques appeared to be more advanced than in the SRV-2-infected macaques but not as severe as those noted in the co-infected macaques. It was not possible to determine equivocally if this was solely attributable to STLV-I infection or was the result of a low-level SRV-2 infection (below the detection limit of our assay), but it is highly improbable that the pathological damage was caused by such an underlying infection. Previous studies have shown that SRV-infected non-viraemic macaques (seropositive but virus-isolation negative) have a much lower incidence and severity of pathological lesions compared with viraemic animals (seropositive and virus-isolation positive) (Guzman et al., 1999) . Furthermore, we have shown previously that transiently infected macaques (seropositive but PCR negative) are able to effectively control replication of SRV-2 and show comparative immunopathology to uninfected macaques (Mitchell et al., 2011; Wilkinson et al., 2003) .
PCR analysis revealed that SRV-2 viral loads were higher in SRV-2/STLV-I-infected macaques than in macaques infected only with SRV-2. SRV-2 was also present in more tissues in co-infected macaques than in macaques infected with SRV-2 alone. Host tissue pathology was more marked in co-infected macaques, with tissue changes evident in the MLN and more adverse tissue pathology in the spleen. The frequency of positive T-cells, B-cells and macrophages was lower in the MLNs of both SRV-2 and co-infected macaques, whilst more intense immune-cell staining and an abnormal distribution of B-cells were observed in the spleen of co-infected macaques compared with SRV-2-infected macaques. 
Effect of retroviral co-infection
There are no published data on SRV-2 viral burden or its effects on host pathology in dual infection with STLV-I. Host immunopathology in SRV-2-infected macaques including those suffering from SRV immunosuppressive AIDS-like disease has been reported (Heidecker et al., 1987; Lerche et al., 1987; Marx et al., 1984; Mitchell et al., 2011) .
Comparisons can be drawn with the data presented here: both SRV-2-and co-infected macaques appeared to exhibit a similar pathology to those macaques persistently infected with SRV-2 and those that developed immunodeficiency syndrome. For instance, similar architectural changes were observed within the lymphoid organs: loss of cellular organization of the red pulp, enlargement/distortion of the follicles and similar immune-cell staining levels (Chalifoux et al., 1984; Guzman et al., 1999; Meyer et al., 1985; Mitchell et al., 2011) . Similarly, B-cell hyperplasia and aberrant distortion of T-cells in the spleen have been described in persistent SRV-2 infection and immunodeficiency disease, as T-cells are shown to migrate into the follicles from the interfollicular region and B-cells are no longer confined to the parafollicular areas (Chalifoux et al., 1984; Meyer et al., 1985; Mitchell et al., 2011) .
The STLV-I proviral burden was comparable between STLV-I-and co-infected macaques, but pathological changes were generally more marked in the co-infected macaques. Whilst a greater degree of B-cell staining was noted in the MLNs of STLV-I-infected macaques, more aberrant T-cell, B-cell and macrophage staining was observed in the spleens of co-infected macaques. Distortion in the Bcell staining patterns was more marked in the co-infected macaques. Together, these observations mirror the events leading to HTLV-I-induced B-cell hyperplasia and lymphomas as an indirect effect of T-cell infection (Mann et al., 1987; Suefuji et al., 2003) .
HTLV-I and STLV-I infections can cause amyloid deposits, follicular hyperplasia and germinal-centre involution within lymphoid tissue (Kazanji et al., 2000; McGinn et al., 2002; Pallesen et al., 1987) . We noted similar pathological changes in both SRV-2 and STLV-I infections; thus, it is plausible that both viruses induce a similar pathology, which is intensified in co-infection. Whilst there are no current reports on STLV-I and SRV-2 co-infections, data available on the pathogenesis of STLV-I in the presence of SIV suggest that co-infection does not enhance SIV-1 disease progression (Fultz et al., 1990 (Fultz et al., , 1999 Harrison et al., 1997) but may potentiate STLV-I-related disease (Traina-Dorge et al., 2007) . Although we did not observe an effect of co-infection on the STLV-I proviral burden, pathogenesis was exaggerated in the co-infected macaques.
We considered the importance of SFV infection on pathology because, as with many captive cohorts, this virus was endemic in the colony. It has been reported that SFV causes a long-term persistent asymptomatic infection with no overt pathology or disease (Linial, 2000; Rustigian et al., 1955) ; we therefore analysed the effects of SRV-2 and STLV-I in isolation from SFV. Whilst we could not completely exclude the possibility that all of these viruses may impact on each other, our data suggested that no observable changes in SFV provirus dynamics occurred in the presence of either SRV-2 or STLV-I (Fig. S1 , available in JGV Online). One interesting observation was seen in the sole SFV-positive, SRV-2/STLV-I-negative macaque in which morphological abnormalities were observed in the spleen, with CD68-positive giant cells being detected. Whilst this macaque may have had an unidentified infection, it is possible that the long-term persistent SFV infection might have contributed to the pathology. This finding suggests that SFV infection may not be completely asymptomatic. This type of cellular change has been observed previously in the small intestine of SFV/SIV coinfected macaques (Murray et al., 2006) ; however, our study provides the first evidence of giant-cell formation in the absence of other detectable retroviruses.
We showed that, in SRV-2/STLV-I-infected macaques, SRV-2 biodistribution was broadened and a more conspicuous immunopathology occurred in the major immune organs. Our data suggested that this was due to the concomitant STLV-I infection. SRV-2 productively infects both T-and B-cells, whilst STLV-I, the simian ancestor of HTLV-I, has a cellular tropism for T-cells (Malley et al., 1991; Maul et al., 1988; Souquière et al., 2009) . HTLV-I is a strong activator of the immune system, causing T-cell proliferation and activation (Jacobson et al., 1990; Minato et al., 1989; Prince et al., 1991) . If parallels can be drawn between STLV-I and HTLV-I kinetics, STLV-I may cause T-cell proliferation, thereby increasing the number of viable target cells in co-infected macaques available for SRV-2 virions to infect. Thus, SRV-2 would spread more readily through the host causing more extensive damage. Conversely, SRV-2 does not cause immune activation, and thus the number of T-cells susceptible to STLV-I entry would be unaltered. Therefore, STLV-I viral dynamics would not differ between co-infected and STLV-I-infected macaques.
This study investigated the impact of natural retroviral infections in macaques and highlighted the importance of retrovirus-free macaques in experimental studies. Our findings, in which STLV-I exacerbated the pathogenesis associated with SRV-2, suggest that co-infections do not greatly alter the burden of individual proviruses but may modify the host microenvironment sufficiently to facilitate the spread of other retroviruses, thereby increasing the chance of adverse pathology.
METHODS
Animal samples. All macaques were housed and maintained in accordance with the UK Home Office guidelines for the care and maintenance of non-human primates. From a cohort of 16 cynomolgus macaques (M. fascicularis), 11 tissue types (tongue, salivary gland, salivary gland lymph node, lung, peripheral lymph nodes, small intestine, large intestine, mesenteric lymph node, liver, kidney and spleen) were available as tissue sections cut from formalin-fixed, paraffin-embedded tissue or from frozen tissues. The SRV-2 and STLV-I infection status, as determined by PCR analysis of provirus in PBMCs, was determined previously as part of a study of a large cohort of macaques (Mee et al., 2009) . This classification was refined in the present study by the additional assessment of proviral load in tissues (Table 1 ). Due to SFV being endemic in our captive-bred breeding colony (unpublished data), 15 of the 16 macaques selected for this study were SFV positive, with only one individual completely negative for all three retroviruses (958EH). The 16 macaques were selected based on the presence of proviral sequences rather than serological data, as we wished to best demonstrate co-infection and thereafter evaluate differences in immunopathology and viral dynamics in macaques with detectable proviral DNA.
Proviral distribution and load quantification. DNA was extracted from frozen tissues from all macaques and the proviral biodistribution and load were assessed. SRV-2 proviral loads were determined as reported previously (Mitchell et al., 2011) . For the SRV-2 quantitative PCR, each sample was assessed in duplicate (undiluted sample and at a concentration of 100 ng ml 21 ). If .20 % variability between results was observed, the samples were retested. The mean proviral load for each sample was calculated and normalized for 100 ng input DNA (equivalent to 15 000 cells). The detection limit of the SRV-2 quantitative PCR assay was 200 proviral copies ml 21 with an overall R 2 value of ¢0.95 and a PCR efficiency of 90-110 %. STLV-I proviral distribution was determined by adapting a published method (Vandamme et al., 1997) . Briefly, amplification was altered to 15 cycles for the first round and 20 cycles for the second round to ensure reactions were terminated within the exponential amplification phases. A limiting-dilution PCR was then performed with a Poisson distribution to calculate proviral loads. This involved 20 PCRs per dilution series to calculate proviral copies: serial dilutions were performed until 10 (±2) of 20 positive PCRs were observed (this was the equivalent of 0.5-0.9 copies per reaction). The precursor frequency was the inverse fraction for a given dilution that gavẽ 50 % positive signal (Waldmann et al., 1987) . Differences in viral distribution and proviral loads were analysed between infection groups using an unpaired t-test. All tests were performed using Prism version 4 (GraphPad Software).
Detection of viral antibodies. Specific antibodies to SRV-2 were detected by ELISA by adapting a published protocol (Wilkinson et al., 2003) as follows. Infected cell lysate was prepared by sonication, blocking was performed for 1 h and plasma was incubated for 2 h. Specific antibodies to STLV-I were detected using a Murex HTLV I+II ELISA kit GE08/81 (Abbott Murex), according to the manufacturer's instructions. This ELISA uses synthetic antigen peptides and recombinant proteins representing immunodominant regions of the envelope and transmembrane regions of HTLV-I and HTLV-II (Courgnaud et al., 2004) . Macaques were considered seronegative if a value of ¡1.48 for SRV-2 (end-point dilution) or ,0.30 for STLV-I was obtained (assay specifications: mean absorbance+0.2).
Analysis of cellular morphology. Sections (4 mm) were cut from formalin-fixed, paraffin-embedded spleen and MLNs taken at termination. Sections were mounted onto glass slides, deparaffinized using xylene and the tissue rehydrated through an ethanol series. H&E staining was performed, the staining pattern visualized by microscopy (Nikon Eclipse E400) and images captured using Metaview software (Meta Imaging software; MDS Analytical Technologies).
Analysis of immune markers by IHC. Sections were deparaffinized and rehydrated as above. IHC was performed using an Omnislide hybridization system (Thermo-Hybaid) using polyclonal or monoclonal antibodies against the CD3, CD20 and CD68 immune proteins and the chromagenic substrate 3,39-diaminobenzidine tetrahydrochloride, as reported previously (Ferguson et al., 2007; Mitchell et al., 2011) . Sections were visualized as for H&E and the levels of immune markers were measured according to a scoring scheme reported previously (Mitchell et al., 2011) assessing both the breadth and intensity of staining (Table 4) .
